Correlation Between Fate Therapeutics and Salarius Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fate Therapeutics and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Fate Therapeutics and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Salarius Pharmaceuticals.

Diversification Opportunities for Fate Therapeutics and Salarius Pharmaceuticals

0.32

Correlation Coefficient

Fate Therapeutics  Salarius Pharmaceuticals

Weak diversification

The 3 months correlation between Fate and Salarius is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Salarius Pharmaceuticals go up and down completely randomly.

Pair Corralation between Fate Therapeutics and Salarius Pharmaceuticals

Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Salarius Pharmaceuticals. In addition to that, Fate Therapeutics is 1.12 times more volatile than Salarius Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about 0.04 per unit of volatility. If you would invest  144.00  in Salarius Pharmaceuticals on September 27, 2024 and sell it today you would earn a total of  5.00  from holding Salarius Pharmaceuticals or generate 3.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Fate Therapeutics  vs.  Salarius Pharmaceuticals

Fate Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Salarius Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Salarius Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Salarius Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Fate Therapeutics and Salarius Pharmaceuticals

The main advantage of trading using opposite Fate Therapeutics and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.

The idea behind Fate Therapeutics and Salarius Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.